BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25655241)

  • 1. Calibration of Ph. Eur. BRP batch 4 for oral poliomyelitis vaccine (OPV).
    Fiore L; De Dominicis A; Daas A; Costanzo A
    Pharmeur Bio Sci Notes; 2014; 2014():18-38. PubMed ID: 25655241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative study for the establishment of the Ph. Eur. BRP for oral poliomyelitis vaccine (OPV) Batch 3 for use in the potency assay.
    Buchheit KH; Daas A; Stalder J
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):67-91. PubMed ID: 12448032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of European Pharmacopoeia BRP batch 2 for inactivated poliomyelitis vaccine for in vitro D antigen assay.
    Fuchs F; Minor P; Daas A; Milne C
    Pharmeuropa Bio; 2003 Jul; 2003(1):23-50. PubMed ID: 14563307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
    Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Pharmacopoeia biological reference preparation for poliomyelitis vaccine (inactivated): collaborative study for the establishment of batch No. 3.
    Martin J; Daas A; Milne C
    Pharmeur Bio Sci Notes; 2016; 2016():135-150. PubMed ID: 28279255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calibration of human coagulation factor VIII concentrate Ph. Eur. BRP Batch 4 for use in potency assays.
    Raut S; Costanzo A; Daniels S; Heath A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):1-29. PubMed ID: 21144486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of the European Pharmacopoeia Biological Reference Preparation (Ph. Eur. BRP) for hepatitis A vaccine type B (Aventis Pasteur) batch 2.
    Buchheit KH; Daas A
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):95-108. PubMed ID: 12448033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calibration of human coagulation factor VII concentrate Ph. Eur. BRP batch 2.
    Dodt J; Costanzo A; Daas A; Hunfeld A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):31-8. PubMed ID: 20223188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calibration of European pharmacopoeia biological reference preparation for diphtheria vaccine (adsorbed) batch 4.
    Stickings P; Rigsby P; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):1-9. PubMed ID: 20144448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative study for the establishment of erythropoietin BRP batch 4.
    Burns C; Bristow AF; Daas A; Costanzo A
    Pharmeur Bio Sci Notes; 2015; 2015():246-53. PubMed ID: 26830170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborative study for the calibration of the Ph. Eur. prekallikrein activator in albumin BRP batches 4, 5 and 6.
    Lackner F; Daas A; Terao E
    Pharmeur Bio Sci Notes; 2015; 2015():1-10. PubMed ID: 26830155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calibration of the Ph. Eur. human coagulation Factor VIII Concentrate BRP batch 6.
    Raut S; Le Tallec D; Costanzo A
    Pharmeur Bio Sci Notes; 2021; 2021():88-100. PubMed ID: 33973517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborative study for the establishment of the Ph. Eur. BRP batch 1 for anti-vaccinia immunoglobulin.
    Fuchs F; Poirier B; Leparc-Goffart I; Buchheit KH
    Pharmeuropa Bio; 2005 Sep; 2005(1):13-8. PubMed ID: 16336934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay.
    Kirschbaum N; Wood L; Lachenbruch P; Weinstein M; Daas A; Rautmann G; Spieser JM; Buchheit KH
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):31-64. PubMed ID: 12448031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of European Pharmacopoeia (Ph. Eur.) Biological Reference Preparations (BRP) batch 2 for rDNA hepatitis B vaccine (method A and B).
    Dobbelaer R; Daas A; Milne C
    Pharmeuropa Bio; 2004 Jan; 2003(2):77-90. PubMed ID: 14960264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collaborative study for the establishment of tetanus vaccine (adsorbed) Third International Standard and European Pharmacopoeia Biological Reference Preparation batch no. 2.
    Sesardic D; Winsnes R; Rigsby P; Gaines-Das R
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):45-72. PubMed ID: 11705100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborative study for the establishment of the human immunoglobulin for electrophoresis Ph. Eur. BRP batch 3.
    Behr-Gross ME; Daas A; Christians S
    Pharmeur Bio Sci Notes; 2014; 2014():71-80. PubMed ID: 25655244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of batch 4 of the Biological Reference Preparation (BRP) for rabies vaccine (inactivated) for veterinary use.
    Daas A; Milne C
    Pharmeuropa Bio; 2004 Dec; 2004(1):17-22. PubMed ID: 15659282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative study for the establishment of erythropoietin BRP batch 3.
    Behr-Gross ME; Daas A; Burns C; Bristow AF
    Pharmeuropa Bio; 2007 Dec; 2007(1):49-66. PubMed ID: 18413137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a biological reference preparation for hepatitis A vaccine (inactivated, non-adsorbed).
    Stalder J; Costanzo A; Daas A; Rautmann G; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):15-29. PubMed ID: 20223187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.